Search - tctmd.com

Displaying 561 - 580 of 808

Sort: Relevancy | Date

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

Presentation TCT 2012

XIMA: A Prospective, Randomized Trial of Everolimus-Eluting Stents vs. Bare-Metal Stents in Octogenarians

Presenter: Adam de Belder

October 26, 2012

Presentation TCT 2012

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

Presenter: Alaide Chieffo

October 26, 2012

Presentation TCT 2012

Reflections on Coronary Stents: From Bare Metal to Drug-Eluting to Bioabsorbable: My Personal Delights and Dilemmas

Presenter: Antonio Colombo

October 26, 2012

Presentation TCT 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Presenter: Bruno Scheller

October 26, 2012

Presentation TCT 2012

Bioabsorbable Drug-Eluting Scaffolds Are the Future! The Science Behind the Dream

Presenter: Patrick Serruys

October 26, 2012

Presentation TCT 2012

Will Polymer-Free DES Be Safer Than Bare Metal Stents?

Presenter: Philip Urban

October 25, 2012

Presentation TCT 2012

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

Presenter: Clemens von Birgelen

October 25, 2012

Presentation TCT 2012

The COAPT Trial: Lessons and Perspectives from the Design Phase

Presenter: Gregg Stone

October 25, 2012

Presentation TCT 2012

The BIOLUX-P-I Trial: Clinical and Angiographic Results

Presenter: Dierk Scheinert

October 25, 2012

Presentation TCT 2012

The Big Picture: Potential Role of DCB in a Mature Coronary DES Market (SeQuent Please Worldwide Registry)

Presenter: Jochen W?hrle

October 25, 2012

Presentation TCT 2012

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

Presenter: Vasim Farooq

October 25, 2012

$SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients$

Presentation TCT 2012

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

Presenter: Deepak Bhatt

October 25, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

RESET 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Sirolimus-Eluting Stents

Presenter: Ken Kozuma

October 25, 2012

Presentation TCT 2012

Regulatory Requirements for DCB Development and Approval in the United States

Presenter: Kenneth Cavanaugh Jr

October 25, 2012

Presentation TCT 2012

Proposals for New Short-Term DAPT Use Trials After DES

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Long-Term Results of Bifurcation Stenting with Everolimus-eluting vs. Sirolimus-eluting Stents: The SEA-CORP BC Trials

Presenter: Francesco Burzotta

October 25, 2012

Presentation TCT 2012

Justifying an OPC Model for DES Approval: General Principals

Presenter: Laura Mauri

October 25, 2012

Advertisement

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

XIMA: A Prospective, Randomized Trial of Everolimus-Eluting Stents vs. Bare-Metal Stents in Octogenarians

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

Reflections on Coronary Stents: From Bare Metal to Drug-Eluting to Bioabsorbable: My Personal Delights and Dilemmas

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Bioabsorbable Drug-Eluting Scaffolds Are the Future! The Science Behind the Dream

Will Polymer-Free DES Be Safer Than Bare Metal Stents?

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

The COAPT Trial: Lessons and Perspectives from the Design Phase

The BIOLUX-P-I Trial: Clinical and Angiographic Results

The Big Picture: Potential Role of DCB in a Mature Coronary DES Market (SeQuent Please Worldwide Registry)

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

RESET 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Sirolimus-Eluting Stents

Regulatory Requirements for DCB Development and Approval in the United States

Proposals for New Short-Term DAPT Use Trials After DES

Long-Term Results of Bifurcation Stenting with Everolimus-eluting vs. Sirolimus-eluting Stents: The SEA-CORP BC Trials

Justifying an OPC Model for DES Approval: General Principals

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content